News search

A team from the CNIC has discovered the key role of conventional type 1 dendritic cells (cDC1) in atherosclerosis and has developed an experimental therapy with immunosuppressive nanoparticles that slows the progression of the disease in animal models.

Dr. Joseph Hill holds the James T. Willerson, M.D., Chair in Cardiovascular Disease and the Frank M. Ryburn Jr. Chair in Cardiac Research at the University of Texas Southwestern Medical Center

CNIC researchers have discovered that the heart is formed from two independent cell types that act in synchrony from the onset of gastrulation. This finding could help to better understand the origin of certain congenital heart defects and open up new opportunities in regenerative medicine and tissue bioengineering.

Dra. Maria Kontaridis currently serves as the Gordon K. Moe Professor and Chair of Biomedical Research and Translational Medicine, as well as is the Executive Director and Director of Research, at the Masonic Medical Research Institute

Dr. Mariell Jessup is Chief Science and Medical Officer of the American Heart Association

Jianyi «Jay» Zhang,  Chair of the Department of Biomedical Engineering (BME), at University of Alabama -Birmingham (UAB).

Dr. Jonathan Kipnis is a Principal Investigator and the Alan A. and Edith L. Wolff Distinguished Professor of Pathology and Immunology at Washington University

Prof. Daniel Ketelhuth leads a research team at the University of Southern Denmark